Resources

The right support to make a difference.


Integrate your medical expertise with our diagnostic tools.

Partnering with multi-disciplinary breast cancer care teams, we are working to overcome the complex challenges of early-stage breast cancer. Genomic testing is a fundamental tool as we approach each decision. It has the unique ability to illuminate an individual’s tumor biology and help guide more personalized treatment strategies.

We have designed our tests to deliver rapid results that you can leverage in patient consultations before and after surgery. Covered by most healthcare plans, they serve as part of our effort to ease financial burdens for patients and expand testing access around the globe.

U.S. Resources

Test Requisition Form

Sample Reports

Instructions for Use

Additional Global Information

NGS Resources ROW

Summary of Safety & Performance (EU Only)

Available upon request via customer service:

customerservice@agendia.com

Included in Major International Guidelines

ASCO Logo

ASCO – Breast Cancer Biomarkers

NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN):

GENE EXPRESSION ASSAYS FOR CONSIDERATION OF ADJUVANT SYSTEMIC THERAPY

ESMO Logo

ESMO Clinical Practice Guideline

St. Gallen Oncology Logo

St. Gallen International Consensus Guidelines

Have more questions?

At Agendia, we are here to support you and your patients through the treatment planning process and beyond.

View upcoming events and conferences.

EVENTS >

Click here for a quick and easy ordering process.

ORDER A TEST >

Suzanne Hoekstra

Ordering MammaPrint and BluePrint is easy, and I am loving having this information so soon in the process because it helps the patient know what to expect.

– Suzanne Hoekstra, MD